BofC // Quick Hits with Guy Chamberland, PhD, Chief Science Officer and Interim CEO, Tetra Bio-Pharma

Guy Chamberland, PhD, Chief Science Officer and Interim CEO of Tetra Bio-Pharma joined us for a Quick Hits conversation about medical cannabis, research, development and the future of the sector in Canada and worldwide.

Tetra Bio-Pharma is Orleans, Ontario-based biopharmaceutical company researching and developing cannabinoid-based drugs. They aim to bring novel drugs and treatments to patients and their healthcare providers.